Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,498,877
-$71,762 QoQ
Shares Held
103,774
+13.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#864
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
This page
|
103,774 | $2,498,877 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,498,877 | 103,774 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,570,639 | 91,547 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,845,588 | 74,120 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,936,352 | 75,995 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,880,418 | 77,575 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,091,969 | 82,556 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,293,438 | 86,447 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,648,588 | 91,520 | Shares | Sole | 2024-11-12 | |
| 2023-12-31 | $3,522,283 | 122,344 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,111,487 | 123,952 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,415,781 | 65,861 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,838,088 | 69,561 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,074,604 | 79,520 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,329,829 | 76,093 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,259,675 | 81,245 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,704,712 | 71,561 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,180,090 | 70,789 | Shares | Other | 2022-01-27 | |
| 2021-09-30 | $3,206,825 | 74,560 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,511,095 | 64,124 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,096,992 | 57,880 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,060,218 | 55,969 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,113,697 | 30,346 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $823,484 | 25,183 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $483,201 | 14,804 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||